| 临床病理特征 | SII | NLR | PLR | MLR | |||||
| 低水平组 (n = 17) | 低水平组 (n = 66) | 低水平组 (n = 26) | 高水平组 (n = 57) | 低水平组 (n = 49) | 高水平组 (n = 34) | 低水平组 (n = 40) | 高水平组 (n = 43) | ||
| 年龄(x ± s，岁) | 53.9 ± 14.3 | 49.8 ± 10.8 | 54.9 ± 12.4 | 48.7 ± 10.8 | 51.0 ± 11.6 | 50.6 ± 11.8 | 52.6 ± 12.8 | 47.7 ± 9.1 | |
| BMI (x ± s, kg/m2) | 24.2 ± 2.9 | 22.8 ± 3.0 | 24.0 ± 2.7 | 23.8 ± 4.1 | 24.0 ± 3.2 | 23.8 ± 3.2 | 24.4 ± 2.9 | 23.4 ± 3.4 | |
| 病理 类型 | 导管癌 | 14 (82.4%) | 54 (81.8%) | 23 (88.5%) | 45 (79.0%) | 42 (85.7%) | 26 (76.5%) | 31 (77.5%) | 37 (86.1%) |
| 小叶癌 | 3 (17.6%) | 1 (1.5%) | 2 (7.70%) | 2 (3.50%) | 3 (6.10%) | 1 (2.90%) | 3 (7.50%) | 1 (2.30%) | |
| 其他 | 0 (0%) | 11 (16.7%) | 1 (3.80%) | 10 (17.5%) | 4 (8.20%) | 7 (20.6%) | 6 (15.0%) | 5 (11.6%) | |
| 分期 | III A | 10 (58.8%) | 30 (45.4%) | 11 (42.3%) | 29 (50.9%) | 23 (46.9%) | 17 (50.0%) | 18 (45.0%) | 22 (51.2%) |
| III B | 2 (11.8%) | 11 (16.7%) | 5 (19.2%) | 8 (14.0%) | 7 (14.3%) | 6 (17.6%) | 5 (12.5%) | 8 (18.6%) | |
| III C | 5 (29.4%) | 25 (37.9%) | 10 (38.5%) | 20 (35.1%) | 19 (38.8%) | 11 (32.4%) | 17 (42.5%) | 13 (20.2%) | |
| 分子 分型 | Luminal A型 | 4 (23.5%) | 13 (19.7%) | 3 (11.5%) | 14 (24.6%) | 8 (16.3%) | 9 (26.5%) | 7 (17.5%) | 10 (23.2%) |
| Luminal B型 | 7 (41.2%) | 33 (50.0%) | 13 (50.0%) | 27 (47.3%) | 24 (49.0%) | 16 (47.1%) | 26 (65.0%) | 14 (32.6%) | |
| HER-2 阳性型 | 5 (29.4%) | 9 (13.6%) | 7 (26.9%) | 7 (12.3%) | 11 (22.4%) | 3 (8.8%) | 3 (7.5%) | 11 (25.6%) | |
| 三阴型 | 1 (5.9%) | 11 (16.7%) | 3 (11.5%) | 9 (15.8%) | 6 (12.3%) | 6 (17.6%) | 4 (10.0%) | 8 (18.6%) | |
| 手术 | 是 | 17 (100%) | 64 (97.0%) | 26 (100%) | 55 (96.5%) | 48 (98.0%) | 33 (97.1%) | 39 (97.5%) | 42 (97.7%) |
| 否 | 0 (0%) | 2 (3.0%) | 0 (0%) | 2 (3.5%) | 1 (2.0%) | 1 (2.9%) | 1 (2.5%) | 1 (2.3%) | |
| 放疗 | 是 | 10 (58.8%) | 47 (71.2%) | 16 (61.5%) | 41 (78.9%) | 33 (67.3%) | 10 (29.4%) | 29 (72.5%) | 28 (65.1%) |
| 否 | 7 (41.2%) | 19 (28.8%) | 10 (38.5%) | 16 (28.1%) | 16 (32.7%) | 24 (70.6%) | 11 (27.5%) | 15 (34.9%) | |
| 化疗 | 是 | 15 (88.2%) | 66 (100%) | 24 (92.3%) | 57 (%) | 47 (95.9%) | 34 (%) | 38 (95%) | 43 (100%) |
| 否 | 2 (11.8%) | 0 (0%) | 2 (7.7%) | 0 (100%) | 2 (4.1%) | 0 (100%) | 2 (5%) | 0 (0%) | |
| 淋巴结 转移 | 是 | 17 (100%) | 61 (92.4%) | 24 (92.3%) | 54 (94.7%) | 47 (96.9%) | 31 (91.2%) | 38 (95%) | 40 (93%) |
| 否 | 0 (0%) | 5 (7.6%) | 2 (7.7%) | 3 (5.3%) | 2 (4.1%) | 3 (8.8%) | 2 (5%) | 3 (7%) | |